Deep Track Capital, LP
CIK 1856083 · Holdings on Sep 30, 2024 · First reported Nov 14, 2024
Top ten holdings
Q3 2024- ARGX6.32%
- DVAX4.46%
- GH4.39%
- APLS4.05%
- IMVT3.96%
- SWTX3.93%
- DYN3.76%
- ITCI3.74%
- OCUL3.53%
- NTLA3.25%
Share classes counted separately41.39%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- AXSMWeight decreased · -1.99 pp4.45% → 2.46%Shares -995.57K (-53.73%)
- IMVTWeight increased · +1.69 pp2.27% → 3.96%Shares +1.46M (+50.76%)
- VRDNWeight increased · +1.20 pp1.52% → 2.72%Shares -172.90K (-4.41%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 28
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | ARGXARGENX SE - ADRSPONSORED ADR View history and evidence | $197.86M | 6.32% | 365.00K shares | 5.14% → 6.32%+1.18 pp -35.00K (-8.75%) | Reduced | ↗▾ |
| 02 | DVAXDYNAVAX TECHNOLOGIES CORPCOM NEW View history and evidence | $139.55M | 4.46% | 12.53M shares | 3.66% → 4.46%+0.80 pp +1.63M (+14.92%) | Added | ↗▾ |
| 03 | GHGUARDANT HEALTH INC View history and evidence | $137.65M | 4.39% | 6.00M shares | 3.88% → 4.39%+0.51 pp +1.50M (+33.35%) | Added | ↗▾ |
| 04 | APLSAPELLIS PHARMACEUTICALS INC View history and evidence | $126.91M | 4.05% | 4.40M shares | 2.86% → 4.05%+1.19 pp +1.90M (+76.03%) | Added | ↗▾ |
| 05 | IMVTIMMUNOVANT INC View history and evidence | $123.95M | 3.96% | 4.35M shares | 2.27% → 3.96%+1.69 pp +1.46M (+50.76%) | Added | ↗▾ |
| 06 | SWTXSPRINGWORKS THERAPEUTICS INC View history and evidence | $123.16M | 3.93% | 3.84M shares | 4.16% → 3.93%-0.23 pp +143.90K (+3.89%) | Added | ↗▾ |
| 07 | DYNDYNE THERAPEUTICS INC View history and evidence | $117.89M | 3.76% | 3.28M shares | 4.22% → 3.76%-0.46 pp -718.00K (-17.95%) | Reduced | ↗▾ |
| 08 | ITCIINTRA-CELLULAR THERAPIES INC View history and evidence | $117.12M | 3.74% | 1.60M shares | 3.15% → 3.74%+0.59 pp +62.77K (+4.08%) | Added | ↗▾ |
| 09 | OCULOCULAR THERAPEUTIX INC View history and evidence | $110.68M | 3.53% | 12.72M shares | 2.60% → 3.53%+0.93 pp 0 (0.00%) | Unchanged | ↗▾ |
| 10 | NTLAINTELLIA THERAPEUTICS INC View history and evidence | $101.72M | 3.25% | 4.95M shares | 3.21% → 3.25%+0.04 pp +150.00K (+3.13%) | Added | ↗▾ |
Options overlay 2
$20.36M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
AXSMAXSOME THERAPEUTICS INC View history and evidence | Call | 200.00K | $17.97M | +200.00K | ▾ |
NMRANEUMORA THERAPEUTICS INC View history and evidence | Call | 180.50K | $2.38M | 0 (0.00%) | ▾ |
2 / 2 options · preview only
Exited positions 9
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| AMGN AMGEN INC | Non-derivative | -575,000 | -$179.66M | SEC filing ↗ | SEC filing ↗ |
| INSM INSMED INC | Non-derivative | -2,000,000 | -$134.00M | SEC filing ↗ | SEC filing ↗ |
| ALNY ALNYLAM PHARMACEUTICALS INC | Non-derivative | -500,000 | -$121.50M | SEC filing ↗ | SEC filing ↗ |
3 / 9 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1856083 · Period 2024-09-30
Data loaded 2026-09-23 · First reported 2024-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 3152681097
}Research all 71 reported holdings.
This page includes 30 of 71 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 71 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1856083","quarter":"2024Q3","page_size":100}
get_institutional_manager_history
{"cik":"1856083","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.